Lethal experimental cancer drug from Hanmi, Boehringer killed three patients — report
Korean health officials have tied the deaths of three patients to a cancer drug launched by Hanmi Pharmaceuticals and partnered with Boehringer Ingelheim, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.